Posted on: February 5, 2014
Counteracting Chronic Pain
Over the past decade, researchers have made quite a few discoveries about the origins of pain, and understanding its source may lead to better treatments in the future.
Often, there are also more options for tackling chronic pain than patients are ever made aware of and, however slowly, some new options have emerged as well.
One of those new options is a drug called Lyrica (pregabalin), significant because it targets nerve pain, a type of pain not usually relieved by NSAIDs (non-steroidal anti-inflammatory drugs) and other common treatments. Lyrica is FDA approved to treat fibromyalgia, diabetic nerve pain, spinal cord injury nerve pain and pain from a shingles attack. “It controls nerve pain and has a lower side effect profile than previous treatments,” said Giovanni Angelino, M.D., R.Ph, and pain management specialist at Northern Westchester Hospital. Continue reading